XML 37 R26.htm IDEA: XBRL DOCUMENT v3.22.1
REVENUE RECOGNITION AND RELATED ALLOWANCES (Tables)
3 Months Ended
Mar. 31, 2022
REVENUE RECOGNITION AND RELATED ALLOWANCES  
Schedule of disaggregation of revenue and revenue recognized

Three Months Ended

Products and Services

March 31, 

March 31, 

(in thousands)

    

2022

    

2021

    

Sales of generic pharmaceutical products

$

49,107

$

32,988

Sales of established brand pharmaceutical products

 

8,452

 

7,517

Sales of rare disease pharmaceutical products

1,292

Sales of contract manufactured products

 

2,904

 

2,573

Royalties from licensing agreements

 

1,903

 

11,210

Product development services

 

566

 

158

Other

 

253

 

75

Total net revenues

$

64,477

$

54,521

Three Months Ended

Timing of Revenue Recognition

March 31, 

March 31, 

(in thousands)

    

2022

    

2021

    

Performance obligations transferred at a point in time

$

63,911

$

54,363

Performance obligations transferred over time

 

566

 

158

Total

$

64,477

$

54,521

Schedule of accruals and allowances

The following table summarizes activity in the consolidated balance sheets for accruals and allowances for the three months ended March 31, 2022 and 2021, respectively:

Accruals for Chargebacks, Returns, and Other Allowances

Administrative

Prompt

Government

Fees and Other

Payment

(in thousands)

    

Chargebacks

    

Rebates

    

Returns

    

Rebates

    

Discounts

Balance at December 31, 2020 (1)

$

88,746

$

7,826

$

27,155

$

8,906

$

3,839

Accruals/Adjustments

 

96,701

 

4,656

 

4,811

 

7,634

 

3,196

Credits Taken Against Reserve

 

(114,114)

(3,810)

 

(3,022)

 

(9,184)

 

(3,959)

Balance at March 31, 2021 (1)

$

71,333

$

8,672

$

28,944

$

7,356

$

3,076

Balance at December 31, 2021 (1)

$

94,066

$

5,492

$

35,831

$

13,100

$

4,642

Accruals/Adjustments

 

152,566

 

2,810

 

6,942

 

9,785

 

5,060

Credits Taken Against Reserve

 

(142,991)

(3,745)

 

(7,219)

 

(10,915)

 

(4,539)

Balance at March 31, 2022 (1)

$

103,641

$

4,557

$

35,554

$

11,970

$

5,163

(1)Chargebacks are included as an offset to accounts receivable in the unaudited interim condensed consolidated balance sheets. Administrative Fees and Other Rebates and Prompt Payment Discounts are included as an offset
to accounts receivable or as accrued expenses and other in the unaudited interim condensed consolidated balance sheets. Returns are included in returned goods reserve in the unaudited interim condensed consolidated balance sheets. Government Rebates are included in accrued government rebates in the unaudited interim condensed consolidated balance sheets.
Schedule of customer concentration

Three Months Ended

March 31, 

March 31, 

    

2022

    

    

2021

    

Customer 1

31

%

28

%

Customer 2

19

%

24

%

Customer 3

14

%

16

%